# Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer

> **NCT03030404** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 733 (actual)

## Conditions studied

- Stomach Neoplasms
- Stomach Cancer
- Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS)
- Hereditary Diffuse Gastric Cancer (HDGC)
- Familial Diffuse Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03030404
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-27
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 733 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030404, "Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03030404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*